Endoscopic hemostasis devices (general surgery) market is advancing with innovative technologies such as hemostatic powders, clips, and thermal devices. Latest methods emphasize minimally invasive procedures, enhancing patient recovery and outcomes. Growth is driven by rising gastrointestinal disorders and aging populations. Insights reveal a focus on improving device efficacy and expanding applications in diverse surgical settings.
Frequently Asked Questions
The market is segmented based on Global Endoscopic Hemostasis Devices (General Surgery) Market, By Mechanical Devices (Clips, Ligation Devices, Suturing Devices and Stents) Injection Devices (Injection and Needles), Thermal Devices (Hemostatic Probes, Hemostatic Forceps, Heater Probe, Argon Plasma Coagulation, Radiofrequency Ablation and Cryotherapy), Topical Devices (Hemostatic Spray and Others), End User Industry (Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Others) – Industry Trends and Forecast to 2031
.
The Global Endoscopic Hemostasis Devices General Surgery Market size was valued at USD 1.50 USD Billion in 2023.
The Global Endoscopic Hemostasis Devices General Surgery Market is projected to grow at a CAGR of 6.21% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
